| Search for content and authors |
|
|
| |
 |
dr Maciej Wieczorek
|
| e-mail: | ***@celonpharma.com |
| phone: | |
| fax: | |
| web: | |
| interest(s): | |
|
Affiliation: |
Celon Pharma Sp. z o.o. |
Participant: |
|
Publications: |
- CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor
- Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
- RNAi - breakthrough technology gives hope for breakthrough therapeutics
|
